A detailed well-referenced update on cardiovascular biomarkers, included in a compendium issue of the periodical.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary disease
May 2, 2018
Filmed at the 2017 EACTS Annual Meeting in Vienna, Austria, Stan Antonides moderates a discussion with David Taggart, Joseph Sabik, and Michael Mack on improving the patency and longevity of vein grafts.
May 1, 2018
The authors performed a patient-level meta-analysis of six randomized trials comparing left internal mammary artery (LIMA) + saphenous vein graft (SVG) versus LIMA + radial artery graft.
April 27, 2018
Patient Care
April 24, 2018
The authors report on a randomized, multicenter, open-label, clinical trial involving 500 patients with 1460 saphenous vein grafts (SVG) who were assigned to three groups: (1) ticagrelor + asprin (ASA), (2) ticagrelor alone, or (3) ASA alone. Neither patients nor physicians were blinded to the allocation. The primary outcome was SVG patency at one
April 20, 2018
Patient Care
The Chinese Red Cross has announced that 25 Afghan children with congenital heart disease will receive free medical treatment in China.
April 20, 2018
The authors present the 5-year follow-up results of the HYBRID trial, wherein 200 patients with multivessel disease requiring revascularization were randomized to either conventional coronary artery bypass grafting (CABG) or hybrid coronary revascularization (HCR). Notably, the patients undergoing HCR had a LIMA to LAD via a minimally invasive appr
April 18, 2018
Coronary artery bypass grafting (CABG), the second most common cardiac procedure in the US, was added to the US Hospital Readmissions Reduction Program in 2015. Given the relatively high rate of readmission after CABG, Zywot and colleagues sought to develop a scale for predicting readmission risk.
April 13, 2018
Patient Care
Michael Mack and Alec Vahanian discuss the state and future of transcatheter mitral valve replacement.
April 6, 2018
Patient Care
A baby in Taiwan is the third-lightest to have undergone repair of a type A interrupted aortic arch and aortopulmonary window.